This study was aimed at evaluating the safety profile, acute and subchronic toxicity of Shirishadi polyherbal ayurvedic compound in rodents, commonly used in the treatment of Bronchial Asthma. Acute toxicity was evaluated in wister albino rats by administering orally graded doses of extract of Albezzia lebbeck, Cyperus rotandus and Solanum xanthocarpum (Shirishadi Compound) in the dose of 2000, 5000 mg/kg, 10, and 20 g/kg body weight of animal and observed continuously for first 4 h and hourly for next 12 h, then 8 hourly for next 56 h (72 h, acute toxicity study). The study had been strictly followed the OECD guidance. Adult Wister albino rats were divided into 3 groups with 5 animals in each group and a control group, fed with doses of 5, 100 mg and 150 mg/ml once in a day for 30 days. Effect of drug was evaluated on hematological parameter after every 7 days and histological study was done after sacrificing the animals on 31st day. The median acute toxicity value (LD50) of the extract was found to be infinite and drug was found to be totally non toxic as after ingestion of 20 g no animal found to be dead. Hematological profile shows no abnormal elevation in level of Serum-Bilirubin, GOT, GPT, urea and creatinine. There was no any evidence of toxicity in histopathological studies.
B r o n c h i a l a s t h m a i s a c h r o n i c inflammatory disease of airways. It may be allergic or nonallergic in origin. Sustain inflammation leads to remodeling of airways and cause diminution of their proper functioning.
Asthma is said to be only prevented and not cure and this fact underlies its pathophysiological distinctiveness. Asthma proves to be lethal in its acute manifestation as acute onset of severe bronchoconstriction may cause grave respiratory distress due to lack of proper oxygen saturation.
Asthma whether acute or chronic always associated with permanent damage of normal architecture of airways and thus need a careful and proper management. Although contemporary medicines proves beneficial and life saving in bronchial asthma but ultimate dependence on corticosteroids and wide range of toxic side effects forces researcher to think in different dimension and search for some alternative remedy that prove beneficial in preventing as well as cure asthma.
In an attempt to search some cheap, effective, and fast acting remedy of bronchial asthma, some ayurvedic compound are prepare and planned to be given in aerosol form through nebulization. Preclinical study of aforementioned said research trial consists of toxicity study of ayurvedic compound in animal model. The route of administration of drug selected consists of both oral and Inhalation route. Whenever an investigator administers a chemical substance to a biological system, different types of interactions can occur and a series of dose-related responses result. In most cases these responses are desired and useful, but there are a number of other effects which are not advantageous. These may or may not be harmful to the patients. The types of toxicity tests which are routinely performed bypharmaceutical manufacturers in the investigation of a new drug involve acute, sub-acute and chronic toxicity. Acute toxicity is involved in estimation of LD50 (the dose which has proved to be lethal (causing death) to 50% of the tested group of animals). Determination of acute oral toxicity is usually an initial screening step in the assessment and evaluation of the toxic characteristics of all compounds. This article reviews the methods so far utilized for the determination of median lethal dose (LD50) and the new changes which could be made. This has to go through the entire process of validation with different categories of substances before its final acceptance by regulatory bodies. The following toxicity studies were performed in the present research trial: i) Acute toxicity study ii) Sub chronic toxicity study Acute Lethality (Barlow et To determine the Median Lethal Dose (LD50) after a single dose administered through oral route which is the intended route of administration in humans. 3.
To identify potential target organs for toxicity, determine reversibility of toxicity, and identify parameters for clinical monitoring. 4.
To help select doses for repeated-dose toxicity tests.
Duration
Mortality within 72 hours was cut-off time for acute toxicity however survival of animals were observed up to 2 weeks following single dose administration. Research Branch of the Institute of Medical Sciences, Banaras Hindu University, Varanasi . The animals were housed in polyvinyl cages and were fed on commercial pellet diet (Amrut, Pranav Agro Industries Ltd, India). They were grouped & housed under standard conditions of temperature (22 ± 2C 0 ), relative humidity (60 ± 5%) and 12:12 light/dark cycle, where lights on at 0700 and off at 1900 h). The saline fed group served as control and one group was treated with a standard drug in each protocol. Before experimentation, the animals were kept on fast for 24 h but water was given ad libitum except during experimental test period. During experiments, animals were also observed for any alteration in their general behavior.
Parameters
All the experiments and the care of the laboratory animals were according to current ethical guidelines by the Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA), Ministry of Environment and Forests, Government of India, New Delhi.
The research protocol was approved by Institutional Research committee of Institute of Medical Sciences, BHU-India.
Plant Material and Extraction
TheplantsAlbezzia lebbeck,Cyprus rotandus & Solanum xanthocarpum, were collected from local market of Varanasi. The identification of the drugs was done by Prof.A.K. Singh, Department of Dravyaguna, S.S.U., Varanasi ( Identification number DG/ AKS / 604). Hydroalcoholic Extraction ( Distilled water: Ethanol = 2:1) of drugs was carried out by hot percolation method through soxhlet appratus. Thereafter extracts were dried using rotatory evaporator and dried extracts were put to the process of standradization.
Drug Treatment
Standradized extract of Ayurvedic compounds dissolved in distilled water was orally administered as graded doses of 50mg, 100mg, & 150mg/ 100g of bwt of animal once daily for 30 days for Subchronic toxicity study. Control rats were treated with equal volume of normal saline. The test substance is administered in a single dose by gavage using a stomach tube or a suitable intubation canula. For Acute toxicity study, standradization extract ofShirishadi Polyherbal Ayurvedic compounds was administer as escalated doses of 200mg, 500mg, 1g & 2g/ 100g bwt to Control  100  101  105  110  112  113  115  105  106  108  110  113  115  118  110  112  114  116  118  120  122  102  103  105  108  110  111  112  100  100  105  106  110  110  112  50mg  115  120  122  125  128  130  134  100  105  108  115  120  122  126  110  115  120  125  130  132  135  105  108  112  115  118  122  125  110  115  118  120  125  128  132  100mg  110  112  115  120  125  130  132  105  110  118  120  122  125  128  100  105  108  110  112  115  118  115  120  125  128  130  132  135  120  124  130  132  135  140  142  150mg  100  102  105  108  110  112  115  115  115  117  119  122  125  128  120  122  124  128  130  133  135  122  125  126  130  132  135  138  108  110  112  115  118  120 One Albino rat of group A weighting was administered 200mg ofShirishadi Hydroalcoholic extract dissolved in 1ml of distilled water orally through intubation cannula.
Step II nd :
The rats were observed for 24 hour and when no toxic side effects appears, four more albino rats were taken in group A and administered 2000mg / Kg body weight of Shirishadi extract. The animals were watch for 48 hours. After 48 hours all the rats were survived with no toxic side effect. Limit Test at 5000 mg/kg
Step I st : One albino rat of Group B 100gm waas treated with 5000mg/ Kg of Shirishadi extract dissolved in distilled water and observed for 48 hrs.The ratsurvived and found healthy after 48 hrs of treatment.
Step II nd : When no observable toxic sign and symptoms appears in the albino rats treated with 5000mg/Kg of polyherbal extracts, two more albino rats in group B were added and administered polyherbal drugs in the dose of 5000mg/Kg. The rats were observed for 48 hours.
As no sign and symptom of toxicity appeared in limit test, 12 more albino rats were taken, divided into two groups and selected for main test.
N e x t e s c a l a t e d d o s e o f e x t r a c t (Shirishadi) was decided to be 10gm/Kg body weight administered in albino rats of Group C . The rats were observed for 48 hrs and when no sing and symptom of toxicity appears six more albino rats were taken and divided into two groups namely D and were given next escalated dose of 20gm/ Kg body weight in two divided dose at the interval of 30 minutes.
As even after administration of trial drug in the dose of 20gm/ Kg body weight, no rat die, LD50 of present trial drug is found to be infinite.
To confirm that the present trial drug is non toxic OECD guidline, Page No. 40, was followed. According to the guideline if 2gms oral administration of drug dose not kill the rodent it should be considered as non -toxic. To establish a "no observable effect level" (NOEL).
2.
To characterize dose-response relationships following repeated doses. 3.
To identify and characterize specific organs affected after repeated administration. 4.
To predict a reasonable and appropriate dose for chronic exposure studies (maximum tolerated dose or MTD).
Duration: 30 days. Test System/Animal System: Rodent Dose Administration : Male and female Wistar albino rats weighing 100 ± 20 g were maintained on standard animal feeds and provided with water ad libitum. The animals were weighed and divided into seven groups of five animals each. After overnight fasting of the rats, the control group received a dose of 0. Weight change 3.
Signs of toxicity 4.
Clinical pathology 5.
Pathology and histopathology
RESULTS AND DISCUSSION
The result shows that Shirishadi polyherbal compound is innocuous and very safe for therapeutic use (Yashada, 2006). There were no abnormalities detected in histopathological study nor any biochemical abnormalities were identified in organ sample of sacrificed rodents after acute toxicity study. In chronic treatment with higher doses, death rate showed 20 and 40% cumulative increase. However there is no evidence of organic toxicity in the animals. Studies may be performed in very exclusive conditions to evaluate the issue of long term safety. The acute toxicity study of the extract (Shirishadi compound) indicated no changes in the behaviour and in the sensory nervous Plate 1. Showing different groups of animal Plate 2. Measuring diet for animals during for toxicity studies sub-chronic toxicity study (Table 2) . Percentage cumulative dead after acute toxicity study was found to be 0% (Table 3) .
Body weight of albino rat's increases propionate with dose of drug but become stabilized at higher doses ( Figure 1 ). As there was increase intake of feed with increasing dose of drug, the (Tables 4 and 5 ). Biochemical analysis showed no toxic or abnormal changes suggesting that drug is safe for long duration internal use (Table 6 ). There was 40% cumulative death in group treated with 150 mg of Shirishadi extract during subchornic study whereas 20% (Table 7) in group treated with 100 mg of extract.
As there were no morbid signs found prior to death and in addition to this there was no any evidence of toxicity in histopathological studies (Plates 11, 12, 13 and 14) excludes the possibility of death due to toxic effect of drug.
